This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
RNR vs. CINF: Which Stock Is the Better Value Option?
by Zacks Equity Research
RNR vs. CINF: Which Stock Is the Better Value Option?
RenaissanceRe (RNR) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
RenaissanceRe (RNR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RenaissanceRe (RNR) Q1 Earnings Beat on Solid Property Segment
by Zacks Equity Research
RenaissanceRe's (RNR) first-quarter results reflect a solid underwriting performance and improved investment income. A rise in expenses partially offsets its quarterly results.
Here's What Key Metrics Tell Us About RenaissanceRe (RNR) Q1 Earnings
by Zacks Equity Research
Although the revenue and EPS for RenaissanceRe (RNR) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
RenaissanceRe (RNR) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of 23.53% and 5.96%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Rate Hikes Impact Allstate's (ALL) New Business in Q1?
by Zacks Equity Research
Allstate's (ALL) first-quarter results are likely to reflect improved underwriting profitability and moderate loss cost trends.
Donegal Group (DGICA) Lags Q1 Earnings Estimates
by Zacks Equity Research
Donegal (DGICA) delivered earnings and revenue surprises of -35% and 0.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Allstate (ALL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Allstate (ALL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why RenaissanceRe (RNR) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
RenaissanceRe (RNR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
RenaissanceRe (RNR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
RenaissanceRe (RNR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RenaissanceRe (RNR) Rises 19.8% in 3 Months: More Growth Ahead?
by Zacks Equity Research
RenaissanceRe's (RNR) rising premiums earned and investment income are major growth drivers.
Why Is RenaissanceRe (RNR) Up 0.1% Since Last Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encore Capital's (ECPG) Q4 Earnings Beat on Higher Collections
by Zacks Equity Research
Encore Capital (ECPG) expects collections to grow by approximately 8% to $2 billion in 2024.
Blue Owl Capital (OBDC) Q4 Earnings Top Estimates, Dividend Up
by Zacks Equity Research
Blue Owl Capital's (OBDC) Q4 results reflect record-high net investment income on the back of increased portfolio average yield, partially offset by an increase in operating expenses.
Employers Holdings' (EIG) Shares Rise 4% on Q4 Earnings Beat
by Zacks Equity Research
Employers Holdings' (EIG) fourth-quarter results reflect new business growth and improved bond yields, partly offset by higher losses and loss adjustment expenses.
Globe Life (GL) Q4 Earnings Beat on Solid Investment Income
by Zacks Equity Research
Globe Life's (GL) Q4 results reflect a rise in insurance underwriting income, improved net investment income and premiums in the Life and Health segments, offset by higher expenses.
Hartford Financial (HIG) Q4 Earnings Top on Earned Premiums
by Zacks Equity Research
Hartford Financial's (HIG) Q4 results reflect strong contributions from the Commercial Lines and Group Benefits businesses. However, escalating expenses acted as a partial offset.
RenaissanceRe (RNR) Q4 Earnings Beat on Solid Investment Income
by Zacks Equity Research
RenaissanceRe's (RNR) fourth-quarter results reflect a solid underwriting performance and improved investment income. A rise in expenses partially offsets its quarterly results.
Compared to Estimates, RenaissanceRe (RNR) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for RenaissanceRe (RNR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
RenaissanceRe (RNR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of 44.77% and 19.60%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Curious about RenaissanceRe (RNR) Q4 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for RenaissanceRe (RNR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Will the Specialty Unit Drive RenaissanceRe (RNR) Q4 Earnings?
by Zacks Equity Research
RenaissanceRe's (RNR) Q4 results are expected to benefit from rate increases in the Property segment and a well-performing specialty business, partly offset by escalating claim expenses.
Selective Insurance (SIGI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Selective Insurance (SIGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why RenaissanceRe (RNR) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.